WallStreetZenWallStreetZen

NASDAQ: DTIL
Precision Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their DTIL stock forecasts and price targets.

Forecast return on equity

Is DTIL forecast to generate an efficient return?

Company
-286.55%
Industry
310.8%
Market
238.59%
DTIL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DTIL forecast to generate an efficient return on assets?

Company
-50.97%
Industry
115.15%
DTIL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DTIL earnings per share forecast

What is DTIL's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$2.91
Avg 2 year Forecast
-$2.85
Avg 3 year Forecast
-$3.37

DTIL revenue forecast

What is DTIL's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$12.5M+1,693.84%
Avg 2 year Forecast
$18.6M+2,563.32%
Avg 3 year Forecast
$23.6M+3,286.68%
DTIL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DTIL revenue growth forecast

How is DTIL forecast to perform vs Biotechnology companies and vs the US market?

Company
224.31%
Industry
118.19%
Market
23.42%
DTIL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DTIL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DTIL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DTIL$4.07N/AN/A
VRCA$5.69$17.00+198.77%Strong Buy
PPBT$0.60N/AN/A
TCRX$0.97$6.50+568.72%Buy
TIL$7.77$125.00+1,508.75%Buy
View Top Biotech Stocks

Precision Biosciences Stock Forecast FAQ

What is DTIL's earnings growth forecast for 2026-2028?

(NASDAQ: DTIL) Precision Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 68.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.82%.

Precision Biosciences's earnings in 2026 is -$83,602,000.On average, 6 Wall Street analysts forecast DTIL's earnings for 2026 to be -$38,537,375, with the lowest DTIL earnings forecast at -$67,686,319, and the highest DTIL earnings forecast at -$13,919,589. On average, 6 Wall Street analysts forecast DTIL's earnings for 2027 to be -$37,828,139, with the lowest DTIL earnings forecast at -$48,068,979, and the highest DTIL earnings forecast at -$17,538,682.

In 2028, DTIL is forecast to generate -$44,712,370 in earnings, with the lowest earnings forecast at -$45,340,740 and the highest earnings forecast at -$44,542,683.

If you're new to stock investing, here's how to buy Precision Biosciences stock.

What is DTIL's revenue growth forecast for 2026-2028?

(NASDAQ: DTIL) Precision Biosciences's forecast annual revenue growth rate of 224.31% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 118.19%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.42%.

Precision Biosciences's revenue in 2026 is $698,000.On average, 6 Wall Street analysts forecast DTIL's revenue for 2026 to be $165,987,779, with the lowest DTIL revenue forecast at $0, and the highest DTIL revenue forecast at $437,075,080. On average, 6 Wall Street analysts forecast DTIL's revenue for 2027 to be $246,443,001, with the lowest DTIL revenue forecast at $0, and the highest DTIL revenue forecast at $634,733,238.

In 2028, DTIL is forecast to generate $313,376,337 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $913,125,009.

What is DTIL's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: DTIL) forecast ROA is -50.97%, which is lower than the forecast US Biotechnology industry average of 115.15%.

What is DTIL's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: DTIL) Precision Biosciences's current Earnings Per Share (EPS) is -$9.00. On average, analysts forecast that DTIL's EPS will be -$2.91 for 2026, with the lowest EPS forecast at -$5.11, and the highest EPS forecast at -$1.05. On average, analysts forecast that DTIL's EPS will be -$2.85 for 2027, with the lowest EPS forecast at -$3.63, and the highest EPS forecast at -$1.32. In 2028, DTIL's EPS is forecast to hit -$3.37 (min: -$3.42, max: -$3.36).

What is DTIL's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: DTIL) forecast ROE is -286.55%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.